The Embarrassment of Riches: Combining SGLT2 Inhibitors and Nonsteroidal Mineralocorticoid Antagonists for the Treatment of Diabetic Kidney Disease

Am J Nephrol. 2021;52(8):605-607. doi: 10.1159/000516214. Epub 2021 Sep 16.

Author

Hermann Haller^{1

2}

Affiliations

¹ Mount Desert Biological Laboratory, Bar Harbor, Maine, USA.
² Hannover Medical School Hannover, Hannover, Germany.

PMID: 34530423
DOI: 10.1159/000516214

No abstract available

Keywords: Diabetes; Kidney; Nephropathy; SGLT2 inhibitors.

Publication types

Editorial

MeSH terms

Diabetic Nephropathies / drug therapy*
Drug Combinations
Humans
Mineralocorticoid Receptor Antagonists / administration & dosage*
Sodium-Glucose Transporter 2 Inhibitors / administration & dosage*

Substances

Drug Combinations
Mineralocorticoid Receptor Antagonists
Sodium-Glucose Transporter 2 Inhibitors